0.6110EUR0.00%Mkt Cap: 51.92M $P/E: —1d ago
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offe…
Industry Peers
Medical Devices$198.81BUSDP/E 36.9
$120.66BUSDP/E 34.7
$125.70BUSDP/E 33.9
$111.66BUSDP/E 24.9
$75.37BUSDP/E 21.1
$53.13BUSDP/E 54.9
$48.43BUSDP/E 19.9
$33.94BUSDP/E 17.2
$33.92BUSDP/E 35.5
$25.08BUSDP/E 20.7
$19.21BUSDP/E 24.5
$16.48BUSDP/E 26.9
$12.87BUSDP/E 80.5
$11.86BUSDP/E 22.6
$11.18BUSD
$10.01BUSDP/E 17.1
$10.51BUSDP/E 28.4
$9.73BUSDP/E 19.8
$9.75BUSDP/E 44.3
$8.82BUSDP/E 25.0
| Headline | Source | Time |
|---|---|---|
Older | ||
PPresse Agence | ||
 Sequana Medical Implants 1st FDA-Approved Medical Device For Liver Treatment By Karen Roman Sequana Medical NV (BRU: SEQUA.BR) said it successfully implanted the alfapump device for treatment of recurrent or refractory ascites due to liver cirrhosis in two patients at the University of Pennsylvania. The alfapump is the first FDA-approved active implantable medical device to automatically remove ascitic fluid from the abdomen, freeing patients of […] | ||